Title |
Coupling of Aggregation and Immunogenicity in Biotherapeutics: T- and B-Cell Immune Epitopes May Contain Aggregation-Prone Regions
|
---|---|
Published in |
Pharmaceutical Research, March 2011
|
DOI | 10.1007/s11095-011-0414-9 |
Pubmed ID | |
Authors |
Sandeep Kumar, Satish K. Singh, Xiaoling Wang, Bonita Rup, Davinder Gill |
Abstract |
Biotherapeutics, including recombinant or plasma-derived human proteins and antibody-based molecules, have emerged as an important class of pharmaceuticals. Aggregation and immunogenicity are among the major bottlenecks during discovery and development of biotherapeutics. Computational tools that can predict aggregation prone regions as well as T- and B-cell immune epitopes from protein sequence and structure have become available recently. Here, we describe a potential coupling between aggregation and immunogenicity: T-cell and B-cell immune epitopes in therapeutic proteins may contain aggregation-prone regions. The details of biological mechanisms behind this observation remain to be understood. However, our observation opens up an exciting potential for rational design of de-immunized novel, as well as follow on biotherapeutics with reduced aggregation propensity. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 3% |
United Kingdom | 1 | 1% |
Unknown | 96 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 31 | 31% |
Student > Ph. D. Student | 21 | 21% |
Student > Bachelor | 11 | 11% |
Student > Master | 8 | 8% |
Other | 6 | 6% |
Other | 10 | 10% |
Unknown | 13 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 18 | 18% |
Biochemistry, Genetics and Molecular Biology | 16 | 16% |
Engineering | 13 | 13% |
Chemistry | 10 | 10% |
Pharmacology, Toxicology and Pharmaceutical Science | 9 | 9% |
Other | 20 | 20% |
Unknown | 14 | 14% |